Unicycive Therapeutics, Inc. Quarterly Quick Ratio in % from Q3 2022 to Q2 2023

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Unicycive Therapeutics, Inc. quarterly Quick Ratio history and growth rate from Q3 2022 to Q2 2023.
  • Unicycive Therapeutics, Inc. Quick Ratio for the quarter ending June 30, 2023 was 25.1 %.
Quick Ratio, Quarterly (%)
Period Value YoY Chg Change % Date
Q2 2023 25.1 Jun 30, 2023
Q1 2023 32.5 Mar 31, 2023
Q4 2022 63.9 Dec 31, 2022
Q3 2022 67 Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.